Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multi-Center, Double-blind, Randomized, Placebo-Controlled, Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

NCT05432960 is registered in ClinicalTrials.gov with R-Pharm International, LLC as lead sponsor.

NCT NCT05432960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multi-Center, Double-blind, Randomized, Placebo-Controlled, Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)
Lead sponsor
R-Pharm International, LLC
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2023
Completion date
August 31, 2025
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adult-onset still's disease, aosd